相关实验视频

Updated: Jan 11, 2026

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

脊柱肌肉缩的预症状检测:一个毁灭性的疾病正在进行革命

¹Department of Pediatric Neurology, Strasbourg University Hospital, avenue Molière, 67098 Strasbourg, France.

Revue neurologique

|November 14, 2025

概括

新生儿查脊髓肌缩 (SMA) 能够早期检测和改变生命的治疗,显著改善患者的治疗结果. 这一战略虽然面临实施障碍,但为管理这种遗传性疾病提供了一种具有成本效益的方法.

科学领域:

遗传学遗传学是一种遗传学.
神经学神经学
公共卫生公共卫生

背景情况:

脊柱肌缩 (SMA) 是一种严重的遗传疾病,影响运动神经元,历史上导致严重的残疾和死亡.
最近疾病修饰疗法的进展提供了变革性的结果,特别是当治疗在症状出现之前开始时.

研究的目的:

审查前症状性SMA检测的科学基础,实际方面以及道德,经济和政治方面的考虑.
评估SMA新生儿查计划在新疗法背景下的影响.

主要方法:

对SMA新生儿查的临床试验和现实生活数据的审查.
对影响计划实施的伦理,经济和政治因素的分析.
检查成本效益研究,比较查与症状后治疗.

主要成果:

新生儿对SMA进行查,然后进行早期治疗,表明患者明显受益,并且具有成本效益.
该战略提出了一个新的范式,挑战医疗保健系统,并提出了关于不确定性和父母信息的伦理考虑.
尽管有证据,但系统的SMA新生儿查计划面临政治障碍,甚至在欧盟内也没有普遍实施.

结论:

预症状性SMA的检测和治疗在管理这种遗传性疾病方面取得了重大进展.
长期跟踪和透明的沟通对于解决与新生儿查相关的伦理问题至关重要.
从SMA新生儿查中获得的经验对于未来的基因组查计划是有价值的.

关键词:

新生儿查新生儿查脊柱肌肉缩脊柱肌肉缩脊柱肌肉缩

更多相关视频

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Published on: March 17, 2012

Electrophysiological Motor Unit Number Estimation MUNE Measuring Compound Muscle Action Potential CMAP in Mouse Hindlimb Muscles

Electrophysiological Motor Unit Number Estimation MUNE Measuring Compound Muscle Action Potential CMAP in Mouse Hindlimb Muscles

Published on: September 25, 2015

相关概念视频

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Satellite Stem Cells and Muscular Dystrophy

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...